Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

NEUROSENSE

Financiado

NEUROendocrine SENSor for Sudden Unexpected Death in Epilepsy (SUDEP) prediction...

NEUROendocrine SENSor for Sudden Unexpected Death in Epilepsy (SUDEP) prediction and prevention NEUROSENSE proposes a novel and visionary technology resulting from the demonstration of the upstream role of arousal in the sudden unexpected death in epilepsy (SUDEP). SUDEP is a societal challenge for which there is neither pre... ver más

31/05/2026

I3S INSTITUTO DE...

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

I3S INSTITUTO DE INVESTIGACAO E INOVACAO EM... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 9 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2022-04-13

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

HORIZON-EIC-2021-PATHFINDEROPEN-01-01: EIC Pathfinder Open 2021

I+D

Cerrada hace 3 años

0% 100%

9 Participantes

I3S INSTITUTO DE INVESTIGAC...

772.70K€ | Lider

UNIVERSITE COTE DAZUR

N.D. | Participante

INSERM

N.D. | Participante

Proyectos interesantes

PRIME A Personalised Living Cell Synthetic Computing Circuit for S... 4M€ Cerrado

RTC-2017-6701-1 "SERAS, Seizure Risk Assessment, dispositivo para la evaluac... 199K€ Cerrado

BES-2013-064573 SISTEMA DE PREDICCION EPILEPTOGENICA EN LAZO CERRADO BASADO... 84K€ Cerrado

TEC2012-33634 SISTEMA DE PREDICCION EPILEPTOGENICA EN LAZO CERRADO BASADO... 294K€ Cerrado

PTQ2021-011802 New paradigm based on Artificial Inteligence for monitoring... 116K€ Cerrado

EDISON EEG-based DIagnosis Support solutiON (EDISON) to help close... 3M€ Cerrado

Últimas noticias

29-11-2024: IDAE En las últimas 48 horas el Organismo IDAE ha otorgado 4 concesiones

29-11-2024: ECE En las últimas 48 horas el Organismo ECE ha otorgado 2 concesiones

29-11-2024: CMVAMADRID En las últimas 48 horas el Organismo CMVAMADRID ha otorgado 37 concesiones

Duración del proyecto: 49 meses Fecha Inicio: 2022-04-13
Fecha Fin: 2026-05-31

Presupuesto del proyecto 4M€

Descripción del proyecto NEUROSENSE proposes a novel and visionary technology resulting from the demonstration of the upstream role of arousal in the sudden unexpected death in epilepsy (SUDEP). SUDEP is a societal challenge for which there is neither prediction nor prevention. Research in the field has for long been refining classic concepts based on the cardiac, respiratory and autonomic nervous systems impairment. Our vision is different and based on the neuroendocrine processes of epileptic seizures and arousal, which are expected to be impaired in SUDEP. The NEUROSENSE project will develop the first SUDEP Medical Device (SMD) prototype supported by artificial intelligence (AI) to anticipate life-threatening seizures and trigger automatic emergency drug administration to prevent SUDEP. This represents the very first viable solution towards a societal-friendly management of epilepsy-derived mortality, thus enabling the prevention of SUDEP worldwide. This will be achieved through the combination of expertise and innovative ideas in epilepsy and SUDEP, biosensors for medical devices, animal models of epilepsy and SUDEP and mathematical modelling. To tackle the objectives of the NEUROSENSE project, a multidisciplinary group of European leading experts in key technological areas will ensure that the complete chain of value is enclosed in a multifaceted analysis. The high-risk character of this joint science and technology research is offset by the multidisciplinary nature of the Consortium, by strong and extensive preliminary data and by the high socio-economic gain resulting from its successful execution. Based in the new SMD technology, we will build a diverse portfolio of future projects that will result in a long-term benefit for people with epilepsy, their families, the economy and society.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores